Rchr
J-GLOBAL ID:201801009481024825   Update date: Jun. 24, 2024

Mori Yutaro

モリ ユウタロウ | Mori Yutaro
Affiliation and department:
Job title: Tenure-Track Assistant Professor
Research field  (6): Biomedical engineering ,  Nephrology ,  Internal medicine - General ,  Clinical pharmacy ,  Physiology ,  Medical biochemistry
Research keywords  (7): Micro Physiological System ,  3D culture ,  disease modeling ,  COVID-19 ,  diabetic kidney disease ,  chronic kidney disease ,  autophagy
Research theme for competitive and other funds  (19):
  • 2023 - 2028 尿細管上皮細胞をターゲットとした新規の糖尿病性腎臓病治療薬の開発
  • 2024 - 2027 Elucidation of Pathophysiology and Drug Development for Chronic Kidney Disease by Using Kidney-on-a-chip Derived from Patients
  • 2023 - 2026 免疫チェックポイント分子の制御による慢性腎臓病の新規治療法開発
  • 2022 - 2026 Drug Discovery for Chronic Kidney Disease Targeting Cellular Senescence and Immune Checkpoint Molecules
  • 2023 - 2025 マイクロ流体デバイスを用いた慢性腎臓病患者由来kidney-on-a-chipの樹立
Show all
Papers (45):
  • Yuta Nakano, Shintaro Mandai, Daiei Takahashi, Ken Ikenouchi, Yutaro Mori, Fumiaki Ando, Koichiro Susa, Takayasu Mori, Soichiro Iimori, Shotaro Naito, et al. Sex Disparities in the Risk of Urgent Dialysis Following Acute Aortic Dissections in Japan: A Real-World Naitionwide Study. SSRN Electronic Journal (Sneak Peek 2.0, iScience). 2024
  • Takayasu Mori, Takuya Fujimaru, Chunyu Liu, Karynne Patterson, Kohei Yamamoto, Takefumi Suzuki, Motoko Chiga, Akinari Sekine, Yoshifumi Ubara, Danny E Miller, et al. CFAP47 is a novel causative gene implicated in X-linked polycystic kidney disease. medRxiv. 2024. 2024.04.05.24304760
  • Yuki Nakao, Yutaro Mori, Makiko Mori, Shintaro Mandai, Tamami Fujiki, Hiroaki Kikuchi, Fumiaki Ando, Koichiro Susa, Takayasu Mori, Yuma Waseda, et al. Recapitulation of Cellular Senescence, Inflammation, and Fibrosis in Human Kidney-Derived Tubuloids by Repeated Cisplatin Treatment. medRxiv. 2024. 2024.03.17.24304404
  • Rena Suzukawa, Shintaro Mandai, Yuta Nakano, Shunsuke Inaba, Hisazumi Matsuki, Yutaro Mori, Fumiaki Ando, View ORCID, ProfileTakayasu Mori, Koichiro Susa, et al. Association between antihypertensive combinations and postoperative mortality and functional decline: a nationwide survey of Japanese adults undergoing major surgeries. medRxiv. 2024. 2024.03.14.24304265
  • Ken Ikenouchi, Daiei Takahashi, Shintaro Mandai, Mizuki Watada, Sayumi Koyama, Motoki Hoshino, Naohiro Takahashi, Wakana Shoda, Tamaki Kuyama, Yutaro Mori, et al. Impact of COVID-19 versus other pneumonia on in-hospital mortality and functional decline among Japanese dialysis patients: a retrospective cohort study. Scientific Reports. 2024. 14. 1
more...
MISC (87):
  • 森 槙子, 仲尾 祐輝, 森 雄太郎. 新たな病態モデルとしての尿細管オルガノイド. BIO Clinica. 2024. 39. 5. 57-61
  • Nakano Yuta, Mandai Shintaro, Naito Shotaro, Fujiki Tamami, Mori Yutaro, Ando Fumiaki, Mori Takayasu, Susa Koichiro, Iimori Soichiro, Sohara Eisei, et al. 骨サルコペニアが死亡率とCKD進行に及ぼす影響 前向き観察コホート研究(Impact of Osteosarcopenia on Mortality and CKD Progression: A Prospective Observational Cohort Study). 日本腎臓学会誌. 2023. 65. 3. 256-256
  • 藤丸 拓也, 蘇原 映誠, 森 崇寧, 千賀 宗子, 萬代 新太郎, 中野 雄太, 森 雄太郎, 安藤 史顕, 須佐 紘一郎, 東海林 隆男, et al. 成人期に末期腎不全に至った患者の遺伝的背景の検討. 日本腎臓学会誌. 2023. 65. 3. 262-262
  • Makiko Mori, Yuki Nakao, Yutaro Mori. Renal tubular organoids as a new pathophysiological model. The CELL. 2023. 55. 4. 76-79
  • 柳 智貴, 蘇原 映誠, 菊池 寛昭, 竹内 恒, 須佐 紘一郎, 藤木 珠美, 森 雄太郎, 安藤 史顕, 萬代 新太郎, 森 崇寧, et al. AMP感知機構をバイパスしたAMPK活性化によるCKDの新規治療戦略の発見. 日本腎臓学会誌. 2023. 65. 3. 254-254
more...
Books (1):
  • 浮腫 : 塩・水過剰、新たな展開とは?
    医薬ジャーナル社 2014 ISBN:9784753227037
Lectures and oral presentations  (143):
  • ヒト患者由来尿細管Organoidは細胞老化・炎症・線維化をも再現し得る新規病態モデルである
    (第3回御茶ノ水腎研究会 2024)
  • 透析非導入の翻意により重症尿毒症状態で晩期導入となった一例
    (2024)
  • 維持血液透析中に右腎巨大血腫が出現し保存加療で改善した一例
    (第69回日本透析医学会学術集会・総会 2024)
  • 維持透析患者における急性B型大動脈解離の院内死亡リスクとBMIとの関連
    (第69回日本透析医学会学術集会・総会 2024)
  • Dapagliflozin protects against cisplatin-induced acute kidney injury on primary human renal tubular epithelial cells (hRTECs)
    (2024)
more...
Works (2):
  • 替えきかぬ 細胞だけに 菌生える
    森 雄太郎 2024 - 2024
  • 渾身の 高額実験 ネガデータ
    森 雄太郎 2024 - 2024
Education (4):
  • 2012 - 2016 Tokyo Medical and Dental University Graduate School of Medical and Dental Sciences Doctoral Program: Medical and Dental Sciences Track
  • 2002 - 2008 Tokyo Medical and Dental University Faculty of Medicine School of Medicine
  • 1999 - 2002 青雲高等学校 普通科
  • 1996 - 1999 長崎大学教育学部附属中学校
Professional career (2):
  • PhD (Tokyo Medical and Dental University)
  • MD (Tokyo Medical and Dental University)
Work history (13):
  • 2022/02 - 現在 Tokyo Medical and Dental University Graduate School of Medical and Dental Sciences Track of Medical and Dental Sciences Assistant Professor, Tenure Track
  • 2020/04 - 2022/01 Japan Society for the Promotion of Science Overseas Research Fellow
  • 2018/04 - 2022/01 Harvard Medical School Division of Renal Medicine, Department of Medicine, Brigham and Women's Hospital Research Fellow in Medicine (HMS) / Research Fellow (BWH)
  • 2016/04 - 2019/03 Tokyo Medican and Dental University Department of Nephrology, Division of Systemic Organ Regulation, Track of Medical and Dental Sciences, Graduate School of Medical and Dental Sciences Adjunct Lecturer
  • 2017/04 - 2018/03 Harvard Medical School Division of Renal Medicine, Department of Medicine, Brigham and Women's Hospital Research Fellow in Medicine (HMS) / POI Sponsored Collaborator (BWH)
Show all
Committee career (5):
  • 2020/04 - 現在 The Japanese Society of Internal Medicine Committee Member of Peer Review for Clinical Summary in Board Certification Examination
  • 2017/04 - 現在 Japanese Society of Nephrology Councillor
  • 2022/04 - 2024/03 Tokyo Medical and Dental University Open Innovation Promotor
  • 2022/09 - 2022/09 国立大学法人 東京医科歯科大学 仕様策定委員
  • 2015/04 - 2017/03 一般社団法人 日本内科学会 病歴要約1次評価委員
Awards (15):
  • 2024/05 - 株式会社EXORPHIA バイオベンチャーあるある川柳大賞 オーディエンス賞 渾身の 高額実験 ネガデータ
  • 2024/04 - The Japanese Society of Internal Medicine Outstanding Instructor Award A case of nephrotic syndrome associated with membranous proliferative glomerulonephritis in post-remission IgA nephropathy, which went into remission with immunosuppressive drugs
  • 2024/01 - バソプレシン・オキシトシン研究会 第33回バゾプレシン・オキシトシン研究会 研究奨励賞 LRBA 複合体はリサイクリングエンドソームにおいてAQP2を効率的に活性化し尿量を調節する
  • 2023/11 - Japan Medical Association Medical Research Encouragement Prize of The Japan Medical Association Elucidation of pathophysiology of chronic kidney disease using patient-derived organoids
  • 2023/03 - Tokyo Medical Association 2022 Tokyo Medical Association Medical Research Award Encouragement Award KIM-1 mediates fatty acid uptake by renal tubular cells to promote progressive diabetic kidney disease
Show all
Association Membership(s) (6):
The Molecular Biology Society of Japan ,  AMERICAN SOCIETY OF NEPHROLOGY ,  JAPANESE SOCIETY OF NEPHROLOGY ,  THE JAPANESE SOCIETY FOR DIALYSIS THERAPY ,  THE JAPANESE SOCIETY OF INTERNAL MEDICINE ,  American Heart Association
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page